NCT07526337 Digital Planning and Clinical Assessment of the Treated Atrophic Posterior Maxilla With a Sinus Lift Procedure: a Cross-sectional Study.
| NCT ID | NCT07526337 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Saint-Joseph University |
| Condition | Alveolar Bone Atrophy |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2026-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-01-01 with a primary completion date of 2026-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Maxillary posterior area is the most challenging site for dental implant placement. Indeed, complex remodeling processes, resulting in changes of the maxillary sinus and shape of the alveolar ridge will cause difficulties in rehabilitating the posterior maxillae sites. Various techniques have been proposed in order to achieve the necessary bone volume for the placement of long term successful implants. However, unbalanced crown to implant ratio remains a risk factor after successful dental implants installation following sinus graft. No study on humans assessed the effect of apical positioning of the implants in posterior grafted sites (sinus graft or sinus graft + vertical GBR) on the following clinical parameters: The peri-implant bone remodeling (vertical bone loss (mm) and probing depth (mm) around the implants, crown bulkiness, emergence profile and crown height, and Patients satisfaction, food impaction (PROM)). This study will elucidate these points and based on the parameter's results, suggest a treatment based classification facilitating the treatment decision-making of the clinicians in case of an atrophic posterior maxilla; aiming to ensure a long-term successful supra-implant rehabilitation which will maintain its bio-mechanically and biological success.
Eligibility Criteria
Inclusion Criteria: * \- Patient aged more than 18 years. * Partially edentulous patients having an implant rehabilitation treated with a sinus lift procedure in the atrophic posterior maxilla. * Patient with no systemic disease that contraindicate the surgical procedure as uncontrolled diabetes mellitus, bleeding disorders, recent myocardial infarction, head and neck radiation, and mental disorders. Exclusion Criteria: * \- Fully Edentulous patients. * Patients presenting sinus pathologies (sinusitis, thickening of the membrane). * Patient smoking more than 20 cigarettes. * Patient taking systemic drugs that could affect bone healing as immune suppressive drugs and bisphosphonates. * Patient with systemic disease that contraindicate the surgical procedure as uncontrolled diabetes mellitus, bleeding disorders, recent myocardial infarction, head and neck radiation, and mental disorders.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07526337 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Alveolar Bone Atrophy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07526337 currently recruiting?
Yes, NCT07526337 is actively recruiting participants. Contact the research team at josephryan.younes@net.usj.edu.lb for enrollment information.
Where is the NCT07526337 trial being conducted?
This trial is being conducted at Beirut, Lebanon.
Who is sponsoring the NCT07526337 clinical trial?
NCT07526337 is sponsored by Saint-Joseph University. The trial plans to enroll 100 participants.